In breast cancer, HIF-1α transcriptionally activates the expression of genes with known functions in cell survival, angiogenesis, metabolic reprogramming, invasion, and metastasis, through binding to hypoxia response elements (HREs) in the promoters of its target genes (Masoud and Li, 2015). This evidence concerns the gene HIF1A and breast carcinoma.